A recent Center for International Blood and Marrow Transplant Research (CIBMTR) report showed that our BMT program had the highest patient severity score among the largest U.S. transplant centers in good standing. Still, our overall outcomes are excellent.
Tammy McNinney, BSN, RN, OCN, a staff nurse within the bone marrow transplant unit, is the 2018 recipient of NewYork-Presbyterian Hospital’s Clinical Nurse Excellence Award.
Weill Cornell Medicine and NewYork-Presbyterian Hospital helped baseball player Michael Mays knock cancer out of the park.
In the past few weeks, devastating storms have forced people out of their homes and away from their cancer care facilities, highlighting a need for better education and preparedness surrounding the medical consequences of natural disasters. Click here for tips to help minimize the harm that a natural disaster or public emergency can cause to your personal health.
On August 2, the United States Food and Drug Administration (FDA) approved the drug ibrutinib for treatment of adults with chronic graft versus host disease (cGVHD).
Kerry McDuffee, an inpatient nurse within the Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP) Bone Marrow and Stem Cell Transplant Program, was named a June 2017 DAISY Award Honoree in recognition of the care and compassion that she provides patients and their families.